Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
about
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Preclinical development of a v ...... based on virus-like particles.
@en
Preclinical development of a v ...... based on virus-like particles.
@en-gb
type
label
Preclinical development of a v ...... based on virus-like particles.
@en
Preclinical development of a v ...... based on virus-like particles.
@en-gb
prefLabel
Preclinical development of a v ...... based on virus-like particles.
@en
Preclinical development of a v ...... based on virus-like particles.
@en-gb
P2093
P2860
P50
P1433
P1476
Preclinical development of a v ...... based on virus-like particles.
@en
P2093
Amy M Smith
Benjamin H M Hunn
Franziska Zabel
Gustavo Cabral de Miranda
Marika Doucet
Martin F Bachmann
Mauricio Ramm
Milena Cioroch
P2860
P304
P356
10.1371/JOURNAL.PONE.0181844
P407
P577
2017-08-10T00:00:00Z